Balchem Corporation (BCPC) Stock Analysis

Q: What is the BCPC stock price target?

Take-profit $170.42 (+2.9% upside). Prior stop was $157.58.

Q: What are the risks of investing in BCPC?

Analyst target reached - limited upside remaining; Expensive valuation; Target reached (2.9% upside); Momentum score 4.4/10 — below 4.5 minimum.

Q: Is BCPC overvalued or undervalued?

Balchem Corporation trades at a P/E of 36.5 (forward 28.5). TrendMatrix value score: 3.8/10. Overall verdict: Sell.

Q: What do analysts say about BCPC?

9 analysts cover BCPC with a consensus score of 4.0/5. Average price target: $201.

SellModerate ConfidenceUpdated 2026-04-30

Basic Materials · Specialty Chemicals

We develop, manufacture, distribute and market specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, plant nutrition, sterilization, fumigation, and industrial markets. Our three reportable segments are strategic businesses that... Read more

$165.58+2.9% A.UpsideScore 5.5/10#8 of 36 Specialty Chemicals

Stop $157.58Target $170.42(analyst − 15%)A.R:R 0.6:1

Analyst target$200.50+21.1%4 analysts

$170.42our TP

$165.58price

$200.50mean

$234

Sell if holding. Analyst target reached at $165.58 — A.R:R 0.6:1 is below the 1.5:1 minimum. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Expensive valuation. Chart setup: No recognized chart pattern (not a breakout, bounce, continuation, recovery, falling knife, or range) — technicals mixed. Score 5.5/10, moderate confidence.

Passes 4/6 gates (clean insider activity, no SEC red flags, earnings proximity no date, semi cycle peak clear). Fails on weak momentum and favorable risk/reward ratio. Suitability: moderate.

Thesis

Rewards

Strong earnings beat streak (3/4)

Risks

Analyst target reached - limited upside remaining

Expensive valuation

Key Metrics

P/E (TTM)36.5

P/E (Fwd)28.5

Mkt Cap$5.6B

EV/EBITDA22.2

Profit Mgn14.9%

ROE12.9%

Rev Growth9.8%

Beta0.95

Dividend0.55%

Rating analysts9

Quality Signals

Piotroski F9/9

Options Flow

P/C2.57bearish

IV45%normal

Material Events(8-K, last 90d)

2026-02-19Item 5.02MEDIUM
As previously announced by Balchem Corporation (the "Company") on March 3, 2025, William A. Backus, Vice President and Chief Accounting Officer, is retiring from his position on March 31, 2026. On February 12, 2026, the Board of Directors of the Company elected Erin L.
SEC filing →

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. Full disclaimer

Rating Breakdown

1 floor-breaker·1 ceiling hit

Overall = weighted sum of the 10 dimension scores. Fundamentals (Value/Quality/Growth) carry 45%; market signals (Momentum/Sentiment/Insider/Peer) carry 40%; structure (Technical/Risk/Catalyst) carries 15%.

DimensionScoreWeightContribution

Value3.815%0.57

Quality6.315%0.94

Growth5.215%0.78

Momentum4.410%0.44

Sentiment6.310%0.63

Insider Activity5.010%0.50

Peer Rank4.410%0.44

Technical Setup8.75%0.43

Risk Profile6.75%0.34

Catalyst7.45%0.37

Overall (Σ contributions)5.44

Small float-rounding may cause last-digit differences between this sum and the displayed Overall.

Priced at a premium — multiples above sector norms. Needs delivery on growth + margins to justify.static

Ev Ebitda

0.0

Peg Ratio

3.1

3.5

Forward Pe

4.3

Analyst Target

5.0

6.6

Forward P/E: 28.5xPEG: 4.05

GatesMomentum 4.4<4.5A.R:R 0.6 < 1.5@spotInsider activity: OKNo SEC red flagsEARNINGS PROXIMITY NO DATESEMI CYCLE PEAK CLEARSuitability: Moderate

RSI

34 · Neutral

↓ 20D MA↓ 50D MA↑ 200D MAGOLDEN CROSSSupport $162.45Resistance $178.70

Price Targets

$158

$170

A.Upside+2.9%

A.R:R0.6:1

Position Sizing

ConvictionNone

Suggested %0.5%

Max %1%

RegimeCautious

Risk Alerts

! Target reached (2.9% upside)

! Momentum score 4.4/10 — below 4.5 minimum

! Reward/Risk 0.6:1 at current price — below 1.5:1 minimum

Earnings

3/4 beats

Next Earnings2026-04-30 (nulld)

Verdict History

reverse chrono — latest first

Loading history...

Verdicts are recorded on every nightly pipeline run. Rows capture transitions (verdict flips, score deltas ≥0.3, entry/TP/SL changes). Rows with a ▶ can be expanded to see the change reason. Aggregate cohort performance is tracked in the recommendation ledger.

Frequently Asked Questions

Is BCPC stock a buy right now?

Sell if holding. Analyst target reached at $165.58 — A.R:R 0.6:1 is below the 1.5:1 minimum. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Expensive valuation. Chart setup: No recognized chart pattern (not a breakout, bounce, continuation, recovery, falling knife, or range) — technicals mixed. Prior stop was $157.58. Score 5.5/10, moderate confidence.

What is the BCPC stock price target?

Take-profit target: $170.42 (+2.9% upside). Prior stop was $157.58. Stop-loss: $157.58.

What are the risks of investing in BCPC?

Analyst target reached - limited upside remaining; Expensive valuation.

Is BCPC overvalued or undervalued?

Balchem Corporation trades at a P/E of 36.5 (forward 28.5). TrendMatrix value score: 3.8/10. Verdict: Sell.

What do analysts say about BCPC?

9 analysts cover BCPC with a consensus score of 4.0/5. Average price target: $201.

What does Balchem Corporation do?We develop, manufacture, distribute and market specialty performance ingredients and products for the nutritional,...